160 related articles for article (PubMed ID: 25168050)
1. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
[TBL] [Abstract][Full Text] [Related]
3. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
4. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
[TBL] [Abstract][Full Text] [Related]
7. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
9. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
11. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
13. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
[No Abstract] [Full Text] [Related]
14. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors: prognostic factors and therapeutic implications.
Rosa F; Alfieri S; Tortorelli AP; Di Miceli D; Papa V; Ricci R; Doglietto GB
Tumori; 2012; 98(3):351-6. PubMed ID: 22825511
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
18. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
[TBL] [Abstract][Full Text] [Related]
19. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
20. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV
Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]